Intellia CEO John M. Leonard disposes of USD 286,764 in common shares
Reuters2026/08/24 20:06- Intellia Therapeutics President and CEO John M. Leonard sold 22,675 common shares on Aug. 20-21.
- Sales priced at USD 12.6 per share on Aug. 20, USD 13 per share on Aug. 21.
- Directly held stake fell to 1,147,064 shares following the transactions.
- Separate trust holding reported at 58,415 shares.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Santander Bank: Japan GPIF does not need to adjust asset allocation policy, $62 billion may face sell-off
Analysts at Spain's Santander Bank stated that Japan’s Government Pension Investment Fund (GPIF) could potentially sell up to $62 billion worth of U.S. Treasury bonds without needing to formally adjust its asset allocation policy.

Health in Tech director Timothy Hayes sells 17,730 common shares for $16,243.80
Ocugen CEO Shankar Musunuri sells common shares worth $589,430.24
Computer Modelling Group held annual shareholder meeting